As of close of business last night, Physicians Realty Trust’s stock clocked out at $10.93, up 0.18% from its previous closing price of $10.91. In other words, the price has increased by $+0.02 from its previous closing price. On the day, 4049683 shares were traded. DOC stock price reached its highest trading level at $11.07 during the session, while it also had its lowest trading level at $10.85.
Ratios:
To gain a deeper understanding of DOC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.66 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.10. In the meantime, Its Debt-to-Equity ratio is 0.76 whereas as Long-Term Debt/Eq ratio is at 0.75.
On May 26, 2023, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $15.50.
On April 20, 2023, Wells Fargo started tracking the stock assigning a Underweight rating and target price of $14.Wells Fargo initiated its Underweight rating on April 20, 2023, with a $14 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 08 when Hall Amy M sold 4,001 shares for $12.58 per share. The transaction valued at 50,333 led to the insider holds 35,824 shares of the business.
Becker Laurie P sold 22,322 shares of DOC for $300,677 on Sep 14. The SVP – Controller now owns 55,776 shares after completing the transaction at $13.47 per share. On Sep 12, another insider, BLACK ALBERT JR, who serves as the Director of the company, bought 2,264 shares for $13.26 each. As a result, the insider paid 30,021 and bolstered with 101,472 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DOC now has a Market Capitalization of 2.61B and an Enterprise Value of 4.55B. As of this moment, Physicians’s Price-to-Earnings (P/E) ratio for their current fiscal year is 62.89, and their Forward P/E ratio for the next fiscal year is 48.60. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.80 while its Price-to-Book (P/B) ratio in mrq is 0.94. Its current Enterprise Value per Revenue stands at 8.38 whereas that against EBITDA is 14.17.
Stock Price History:
Over the past 52 weeks, DOC has reached a high of $15.36, while it has fallen to a 52-week low of $10.52. The 50-Day Moving Average of the stock is 12.60, while the 200-Day Moving Average is calculated to be 12.98.
Shares Statistics:
It appears that DOC traded 2.43M shares on average per day over the past three months and 3.62M shares per day over the past ten days. A total of 238.52M shares are outstanding, with a floating share count of 236.10M. Insiders hold about 1.18% of the company’s shares, while institutions hold 89.76% stake in the company. Shares short for DOC as of Jan 31, 2024 were 4.61M with a Short Ratio of 1.89, compared to 3.46M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 1.93% and a Short% of Float of 2.83%.
Dividends & Splits
With its trailing 12-month dividend rate of 0.92, DOC has a forward annual dividend rate of 0.92. Against a Trailing Annual Dividend Yield of 8.43%, it implies a Forward Annual Dividend Yield of 8.42%. The stock’s 5-year Average Dividend Yield is 5.61.
Earnings Estimates
As of right now, 2 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.05 for the current quarter, with a high estimate of $0.06 and a low estimate of $0.05, while EPS last year was $0.04. The consensus estimate for the next quarter is $0.05, with high estimates of $0.05 and low estimates of $0.05.
Analysts are recommending an EPS of between $0.23 and $0.2 for the fiscal current year, implying an average EPS of $0.21. EPS for the following year is $0.22, with 3 analysts recommending between $0.25 and $0.21.
Revenue Estimates
In the current quarter, 4 analysts expect revenue to total $138.28M. It ranges from a high estimate of $141.6M to a low estimate of $131.66M. As of the current estimate, Physicians Realty Trust’s year-ago sales were $134.34M, an estimated increase of 2.90% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $140.4M, an increase of 3.90% over than the figure of $2.90% in the same quarter last year. There is a high estimate of $144.3M for the next quarter, whereas the lowest estimate is $135.66M.
A total of 5 analysts have provided revenue estimates for DOC’s current fiscal year. The highest revenue estimate was $583.8M, while the lowest revenue estimate was $547.67M, resulting in an average revenue estimate of $567.86M. In the same quarter a year ago, actual revenue was $543.46M, up 4.50% from the average estimate. Based on 3 analysts’ estimates, the company’s revenue will be $602.17M in the next fiscal year. The high estimate is $627M and the low estimate is $580.52M. The average revenue growth estimate for next year is up 6.00% from the average revenue estimate for this year.
